Shanghai INT Medical Instruments Co

Shanghai INT Medical Instruments Co EBITDA Margin

The EBITDA Margin of Shanghai INT Medical Instruments Co (1501.HK) as of Oct 22, 2026 is 25.48 %. In the previous year, EBITDA Margin was 25.38 % — a change of 0.39% (higher).

EBITDA Margin

25.48 %

YoY

0.39%

Last updated:

EBITDA Margin of Shanghai INT Medical Instruments Co is 2025 25.48 % . EBITDA Margin of Shanghai INT Medical Instruments Co was 2024 25.38 % . It decreases by 0.39% higher compared to the previous year.

The Shanghai INT Medical Instruments Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
33.49 CNY
Jan 1, 2019
39.71 CNY
Jan 1, 2020
38.27 CNY
Jan 1, 2021
33.64 CNY
Jan 1, 2022
24.80 CNY
Jan 1, 2023
23.69 CNY
Jan 1, 2024
25.38 CNY
Jan 1, 2025
25.48 CNY
The Shanghai INT Medical Instruments Co EBITDA Margin history
YEAREBITDA MarginYoY
25.48 %+0.39%
25.38 %+7.14%
23.69 %-4.48%
24.80 %-26.29%
33.64 %-12.10%
38.27 %-3.61%
39.71 %+18.57%
33.49 %-3.49%
34.70 %-6.14%
36.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai INT Medical Instruments Co Stock analysis

What does Shanghai INT Medical Instruments Co do? Shanghai Kindly Medical Instruments Co., Ltd. generates revenue through the research and development, manufacturing, and sales of interventional and implantable medical devices. The company's cardiovascular intervention business focuses on cardiovascular interventional medical devices, related molds, and accessories, with main products including inflation device, Introducer set, and guidewire. It serves domestic and overseas markets such as Europe and the United States, targeting healthcare providers and medical institutions that require specialized equipment for minimally invasive procedures. The firm expands its product portfolio beyond cardiovascular devices to include neurological interventional medical devices and endocardia implantable medical devices, catering to diverse clinical needs. Its domestic market presence is complemented by exports to Europe and the United States, where it supplies hospitals and clinics seeking high-quality medical devices for patient care. The company's full-time workforce of 1,532 employees supports these operations, ensuring consistent production and delivery of its medical device solutions. Shanghai Kindly Medical Instruments Co., Ltd. operates with a clear focus on interventional and implantable medical devices, leveraging its R&D capabilities to develop specialized products. Its business model relies on direct sales of these devices to healthcare facilities, with no mention of third-party partnerships or additional revenue streams beyond the core product lines described. Shanghai INT Medical Instruments Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai INT Medical Instruments Co stock

EBITDA Margin of Shanghai INT Medical Instruments Co is 25.48 % in 2025.

EBITDA Margin of Shanghai INT Medical Instruments Co changed from 25.38 % to 25.48 %, representing a 0.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Shanghai INT Medical Instruments Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Shanghai INT Medical Instruments Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Shanghai INT Medical Instruments Co

All Key Metrics — Shanghai INT Medical Instruments Co